Drug Shortage Report for APO-VENLAFAXINE XR
Report ID | 165727 |
Drug Identification Number | 02331705 |
Brand name | APO-VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE XR |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 500 BTL |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-26 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-09-01 |
Company comments | 100 BTL is available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.